A case of malignant paraganglioma of the urinary bladder treated with cyclophosphamide, vincristine, and dacarbazine chemotherapy and metaiodobenzylguanidine therapy

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

A 34-year-old man, diagnosed with paraganglioma of the urinary bladder, was referred to our hospital. Computed tomography showed a bladder tumor measuring 64 mm along with right obturator lymphadenopathy. Abnormal uptake was observed on 123 I-MIBG scintigraphy. The tumor was, therefore, diagnosed as malignant paraganglioma. We performed cystectomy, pelvic lymph node dissection, and neobladder reconstruction. Pathological examination revealed a malignant paraganglioma of the urinary bladder with right obturator lymph node metastasis. Postoperatively, both the uptake on 123 I-MIBG scintigraphy and catecholamine levels in blood and urine normalized. However, 22 months later, positoron emission tomography-computed tomography showed the presence of 2 recurrent tumors in the pelvis. The patient underwent 9 courses of cyclophosphamide, vincristine, and dacarbazine chemotherapy and MIBG radiotherapy twice, following which the tumor size decreased by 35% and catecholamine levels normalized once again. At about 2 years of follow-up, the patient was found to be free of recurrence.

Cite

CITATION STYLE

APA

Yamauchi, Y., Matsukawa, Y., Kato, M., Yoshino, Y., Yamamoto, T., Kobayashi, H., & Gotoh, M. (2018). A case of malignant paraganglioma of the urinary bladder treated with cyclophosphamide, vincristine, and dacarbazine chemotherapy and metaiodobenzylguanidine therapy. Japanese Journal of Urology, 109(2), 106–110. https://doi.org/10.5980/jpnjurol.109.106

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free